About this trial
This study aims to study the safety and efficacy of using an 18 mm short vitrectomy probe for pediatric vitreoretinal surgeries and to investigate the surgeon's comfort and reliability of using the shorter probe.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients less than 18 years old
Need vitrectomy due to various etiologies, including retinopathy of prematurity, familial exudative vitreoretinopathy, persistent fetal vasculature, congenital cataract, lens dislocation, open-globe injury, vitreous hemorrhage, or other vitreoretinal diseases.
Disqualifiers
Patients who cannot cooperate fully with detailed ophthalmic examinations.
Trial design
Single group
Treatments tested in this trial
Pars plana vitrectomy with a 18 mm short vitrector
DeviceUsing the shorter 18 mm vitrector for various pediatric vitreoretinal surgeries
Treatment groups
Trial outcomes
Primary outcomes
SAFETY of 18 mm vitrectomy probe in pediatric vitreoretinal surgery
Incidence of iatrogenic injury as assessed by the percentage of surgery with iatrogenic injury event
SAFETY of 18 mm vitrectomy probe in pediatric vitreoretinal surgery
Incidence of intraoperative instrument bending as assessed by the percentage of surgery with instrument bending event
Secondary outcomes
EFFICACY of 18 mm vitrectomy probe in pediatric vitreoretinal surgery
Incidence of retinal detachment as assessed by ophthalmoscopy
EFFICACY of 18 mm vitrectomy probe in pediatric vitreoretinal surgery
Visual acuity as assessed by the Snellen Chart
SATISFACTION of surgeon while using 18 mm short vitrectomy probe for pediatric vitreoretinal surgery
The surgeon's satisfaction score as accessed by a satisfaction questionnaire that includes a scale from 0 (least satisfaction) to 5 (max satisfaction)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.